Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2276 - 2300 of 6046 in total
Sub Class LM ID Name ▼ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Gangliosides LMSP0601CY05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262560 1938.081297 C91H163N3O40
Gangliosides LMSP0601CY04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262559 1910.049997 C89H159N3O40
Gangliosides LMSP0601CY03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262558 1882.018697 C87H155N3O40
Gangliosides LMSP0601CY02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262557 1853.987397 C85H151N3O40
Gangliosides LMSP0601CY01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262556 1825.956097 C83H147N3O40
Gangliosides LMSP0601CY00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer
GSG1298
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • type IV B antigen(d18:1/26:1(17Z))
44260251 1835.054353 C88H158N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type IV B antigen(d18:1/26:0)
44260249 1837.070003 C88H160N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • type IV B antigen(d18:1/24:1(15Z))
44260250 1807.023053 C86H154N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type IV B antigen(d18:1/24:0)
44260248 1809.038703 C86H156N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type IV B antigen(d18:1/22:0)
44260247 1781.007403 C84H152N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type IV B antigen(d18:1/20:0)
44260246 1752.976103 C82H148N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type IV B antigen(d18:1/18:0)
44260245 1724.944803 C80H144N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type IV B antigen(d18:1/16:0)
44260244 1696.913503 C78H140N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • type IV B antigen
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261651 1835.054353 C88H158N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261649 1837.070003 C88H160N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261650 1807.023053 C86H154N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261648 1809.038703 C86H156N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261647 1781.007403 C84H152N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261646 1752.976103 C82H148N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261645 1724.944803 C80H144N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261644 1696.913503 C78H140N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer
GSG1364
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV08
  • Gala 1-3Lex(d18:1/26:1(17Z))
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261555 1673.001528 C82H148N2O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024